Interleukin-6 and Interferon-α Signaling via JAK1–STAT Differentially Regulate Oncolytic versus Cytoprotective Antiviral States
Malignancy-induced alterations to cytokine signaling in tumor cells differentially regulate their interactions with the immune system and oncolytic viruses. The abundance of inflammatory cytokines in the tumor microenvironment suggests that such signaling plays key roles in tumor development and the...
Main Authors: | Oded Danziger, Tal Pupko, Eran Bacharach, Marcelo Ehrlich |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2018.00094/full |
Similar Items
-
Oncolytic virotherapy
by: Daniel Cervantes-García;, et al.
Published: (2008-01-01) -
Current understanding of reovirus oncolysis mechanisms
by: Phillips MB, et al.
Published: (2018-06-01) -
The Nucleoprotein and Phosphoprotein of Peste des Petits Ruminants Virus Inhibit Interferons Signaling by Blocking the JAK-STAT Pathway
by: Pengfei Li, et al.
Published: (2019-07-01) -
Viral Oncolytic Therapy
by: Omar Zurkiya, et al.
Published: (2017-07-01) -
Going (Reo)Viral: Factors Promoting Successful Reoviral Oncolytic Infection
by: Tarryn Bourhill, et al.
Published: (2018-08-01)